Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Signal Transduction and Targeted Therapy
|
May 24, 2021
FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation
Ruiqi Zhu, Li Li, Bao Nguyen, et al.
Blood
|
January 11, 2014
TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo
Hayley Ma, Bao Nguyen, Li Li, et al.
The Neurohospitalist
|
December 17, 2019
Chronic Lymphocytic Leukemia Resulting in Hemorrhagic Brain Masses After Sepsis
Aaron M Gusdon, Sung-Min Cho, Yunis Mayasi, et al.
Oncotarget
|
September 26, 2018
Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3
Kozo Nagai, Lihong Hou, Li Li, et al.
Plos One
|
June 2, 2020
Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera
Jerry L Spivak, Akil Merchant, Donna M Williams, et al.
American Journal of Clinical Pathology
|
April 11, 2023
B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: Report from the 2021 SH/EAHP Workshop
Wenbin Xiao, Catalina Amador, James R Cook, et al.
Blood
|
February 11, 2012
Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model
Sarah Greenblatt, Li Li, Christopher Slape, et al.
The Journal of Biological Chemistry
|
January 24, 2008
Expression of tetraspan protein CD63 activates protein-tyrosine kinase (PTK) and enhances the PTK-induced inhibition of ROMK channels
Daohong Lin, Erik-Jan Kamsteeg, Yan Zhang, et al.
American Journal of Clinical Pathology
|
May 11, 2023
Transdifferentiation, phenotypic infidelity, progression, and transformation in T/NK-cell neoplasms: Report from the 2021 SH/EAHP Workshop
Catalina Amador, James R Cook, Magdalena Czader, et al.
Haematologica
|
July 2, 2026
Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma
Tarek H Mouhieddine, Junia Vieira Dos Santos, Harshita Sehgal, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Signal Transduction and Targeted Therapy
|
May 24, 2021
FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation
Ruiqi Zhu, Li Li, Bao Nguyen, et al.
Blood
|
January 11, 2014
TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo
Hayley Ma, Bao Nguyen, Li Li, et al.
The Neurohospitalist
|
December 17, 2019
Chronic Lymphocytic Leukemia Resulting in Hemorrhagic Brain Masses After Sepsis
Aaron M Gusdon, Sung-Min Cho, Yunis Mayasi, et al.
Oncotarget
|
September 26, 2018
Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3
Kozo Nagai, Lihong Hou, Li Li, et al.
Plos One
|
June 2, 2020
Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera
Jerry L Spivak, Akil Merchant, Donna M Williams, et al.
American Journal of Clinical Pathology
|
April 11, 2023
B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: Report from the 2021 SH/EAHP Workshop
Wenbin Xiao, Catalina Amador, James R Cook, et al.
Blood
|
February 11, 2012
Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model
Sarah Greenblatt, Li Li, Christopher Slape, et al.
The Journal of Biological Chemistry
|
January 24, 2008
Expression of tetraspan protein CD63 activates protein-tyrosine kinase (PTK) and enhances the PTK-induced inhibition of ROMK channels
Daohong Lin, Erik-Jan Kamsteeg, Yan Zhang, et al.
American Journal of Clinical Pathology
|
May 11, 2023
Transdifferentiation, phenotypic infidelity, progression, and transformation in T/NK-cell neoplasms: Report from the 2021 SH/EAHP Workshop
Catalina Amador, James R Cook, Magdalena Czader, et al.
Haematologica
|
July 2, 2026
Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma
Tarek H Mouhieddine, Junia Vieira Dos Santos, Harshita Sehgal, et al.
Page
of 3